D'AMATO, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 3.114
AS - Asia 1.917
EU - Europa 851
SA - Sud America 216
AF - Africa 134
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 6.246
Nazione #
US - Stati Uniti d'America 3.045
SG - Singapore 1.035
CN - Cina 482
DE - Germania 257
IT - Italia 205
BR - Brasile 157
HK - Hong Kong 112
VN - Vietnam 100
MA - Marocco 99
NL - Olanda 57
FI - Finlandia 50
CA - Canada 44
GB - Regno Unito 44
FR - Francia 43
EE - Estonia 39
PK - Pakistan 33
IN - India 30
AR - Argentina 27
PL - Polonia 25
SE - Svezia 21
ID - Indonesia 20
RU - Federazione Russa 20
BD - Bangladesh 16
BE - Belgio 16
MX - Messico 15
UA - Ucraina 15
ZA - Sudafrica 15
TR - Turchia 14
ES - Italia 12
JP - Giappone 10
TH - Thailandia 9
CO - Colombia 8
LT - Lituania 7
MY - Malesia 7
CZ - Repubblica Ceca 6
KR - Corea 6
RO - Romania 6
VE - Venezuela 6
AU - Australia 5
EC - Ecuador 5
EG - Egitto 5
IQ - Iraq 5
IR - Iran 5
UZ - Uzbekistan 5
CL - Cile 4
GR - Grecia 4
IL - Israele 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
AT - Austria 3
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
PE - Perù 3
PH - Filippine 3
SA - Arabia Saudita 3
TN - Tunisia 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CH - Svizzera 2
CR - Costa Rica 2
CY - Cipro 2
DK - Danimarca 2
DZ - Algeria 2
HU - Ungheria 2
JE - Jersey 2
JM - Giamaica 2
KE - Kenya 2
LK - Sri Lanka 2
OM - Oman 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KZ - Kazakistan 1
LB - Libano 1
LS - Lesotho 1
LU - Lussemburgo 1
LY - Libia 1
ML - Mali 1
NG - Nigeria 1
NR - Nauru 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.246
Città #
Dallas 911
San Jose 534
Ashburn 405
Singapore 311
Frankfurt am Main 176
Chandler 161
Hefei 133
The Dalles 127
Hong Kong 108
Casablanca 96
Munich 62
Beijing 53
Atlanta 45
Helsinki 42
Boardman 37
Los Angeles 35
Ho Chi Minh City 34
Chicago 27
Islamabad 26
Lawrence 26
Princeton 26
New York 23
Santa Clara 23
São Paulo 23
Warsaw 22
Boston 18
Hanoi 18
Miami 18
Phoenix 18
Amsterdam 17
Milan 17
Columbus 16
Orem 16
Seattle 16
Brooklyn 14
Brussels 14
Council Bluffs 14
Montreal 14
Rome 13
Stockholm 12
Manchester 11
Mexico City 10
Johannesburg 9
Minneapolis 9
Bangkok 8
Barnet 8
Charlotte 8
Chennai 8
Rio de Janeiro 8
Tokyo 8
Ankara 7
San Francisco 7
Toronto 7
Turku 7
Guangzhou 6
Haiphong 6
Hillsboro 6
Las Vegas 6
Shanghai 6
St Petersburg 6
Washington 6
Boca Raton 5
Denver 5
Borås 4
Boydton 4
Buffalo 4
Dhaka 4
Hangzhou 4
Hải Dương 4
Jacksonville 4
Kuala Selangor 4
London 4
New Delhi 4
Olomouc 4
Rockville 4
Roubaix 4
Sydney 4
Tashkent 4
Thái Bình 4
Verona 4
West Jordan 4
Asker 3
Bishkek 3
Biên Hòa 3
Brasília 3
Cairo 3
Calgary 3
Cleveland 3
Da Nang 3
Dunedin 3
Istanbul 3
Naples 3
Orangeburg 3
Pretoria 3
Quito 3
Sainte-Sophie 3
Secaucus 3
Surakarta 3
Anyang-si 2
Aparecida de Goiânia 2
Totale 3.995
Nome #
A 1 year course of starch- and sucrose-reduced diet used by irritable bowel syndrome patients with diarrhoea and the effect of genetic variants 563
Stratified analyses refine association between TLR7 rare variants and severe COVID-19 243
A second update on mapping the human genetic architecture of COVID-19 224
Preclinical Protein Signatures of Crohn’s Disease and Ulcerative Colitis: A Nested Case-Control Study Within Large Population-Based Cohorts 219
Mapping the human genetic architecture of COVID-19 134
A GWAS meta-analysis from 5 population-based cohorts implicates ion channel genes in the pathogenesis of irritable bowel syndrome 109
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality 87
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes 86
A survey of functional dyspepsia in 361,360 individuals: Phenotypic and genetic cross-disease analyses 79
Fecal Biomarkers of Neutrophil and Eosinophil Origin Reflect the Response to Biological Therapy and Corticosteroids in Patients With Inflammatory Bowel Disease 65
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations 61
Applicability of polygenic risk scores in endometriosis clinical presentation 61
A Starch- and Sucrose-Reduced Diet in Irritable Bowel Syndrome Leads to Lower Circulating Levels of PAI-1 and Visfatin: A Randomized Controlled Study 60
Collagenous Colitis Is Associated With HLA Signature and Shares Genetic Risks With Other Immune-Mediated Diseases 60
Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders 60
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 60
Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease 60
Genetics of irritable bowel syndrome 58
Adult sucrase-isomaltase deficiency masquerading as IBS 58
C13orf31 (FAMIN) is a central regulator of immunometabolic function 58
Large-scale association analyses identify host factors influencing human gut microbiome composition 57
A GWAS meta-analysis suggests roles for xenobiotic metabolism and ion channel activity in the biology of stool frequency 57
Female-Specific Association Between Variants on Chromosome 9 and Self-Reported Diagnosis of Irritable Bowel Syndrome 56
Genetics of irritable bowel syndrome: shifting gear via biobank-scale studies 55
Analysis of 1135 gut metagenomes identifies sex-specific resistome profiles 54
Increased Prevalence of Rare Sucrase-isomaltase Pathogenic Variants in Irritable Bowel Syndrome Patients 54
A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis 54
A meta‐analysis of reflux genome‐wide association studies in 6750 Northern Europeans from the general population 54
Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci 53
Multi-Omics Analyses Show Disease, Diet, and Transcriptome Interactions With the Virome 53
Genome-wide analysis of 944 133 individuals provides insights into the etiology of haemorrhoidal disease 53
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 53
A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn’s Disease and Human Gut Microbiome Composition 52
Analysis of Systemic Epigenetic Alterations in Inflammatory Bowel Disease: Defining Geographical, Genetic and Immune-Inflammatory influences on the Circulating Methylome 50
GWAS of stool frequency provides insights into gastrointestinal motility and irritable bowel syndrome 50
Association of TNFSF15 polymorphism with irritable bowel syndrome 50
Functional variants in the sucrase–isomaltase gene associate with increased risk of irritable bowel syndrome 50
HLA Associations Distinguish Collagenous From Lymphocytic Colitis 49
Reduced efficacy of low FODMAPs diet in patients with IBS-D carrying sucrase-isomaltase (SI) hypomorphic variants 49
Microscopic colitis 48
Faecal microbiota composition associates with abdominal pain in the general population 48
Fine-mapping inflammatory bowel disease loci to single-variant resolution 48
A starch- and sucrose-reduced dietary intervention in irritable bowel syndrome patients produced a shift in gut microbiota composition along with changes in phylum, genus, and amplicon sequence variant abundances, without affecting the micro-RNA levels 48
Functional Analyses of the Crohn’s Disease Risk Gene LACC1 47
A pilot genome‐wide association study meta‐analysis of gastroparesis 47
Constipation is associated with an increased risk of major adverse cardiac events in a UK population 46
Systemic Inflammation in Preclinical Ulcerative Colitis 46
Loss-of-Function of the Voltage-Gated Sodium Channel NaV1.5 (Channelopathies) in Patients With Irritable Bowel Syndrome 46
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 45
A Starch- and Sucrose-Reduced Diet Has Similar Efficiency as Low FODMAP in IBS—A Randomized Non-Inferiority Study 45
Mendelian randomisation shows diverticular disease and irritable bowel syndrome increase the risk of haemorrhoidal disease 45
Dense genotyping of immune-related loci identifies HLA variants associated with increased risk of collagenous colitis 45
Association Between Collagenous and Lymphocytic Colitis and Risk of Severe Coronavirus Disease 2019 45
Gastrointestinal Infection and Risk of Microscopic Colitis: A Nationwide Case-Control Study in Sweden 44
Exploring the genetics of irritable bowel syndrome: a GWA study in the general population and replication in multinational case-control cohorts 44
Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease 43
Rome III Criteria Capture Higher Irritable Bowel Syndrome SNP-Heritability and Highlight a Novel Genetic Link With Cardiovascular Traits 42
Association of Polygenic Risk Score and Bacterial Toxins at Screening Colonoscopy with Colorectal Cancer Progression: A Multicenter Case-Control Study 42
Pathogenesis of Microscopic Colitis: A Systematic Review 42
Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data 42
Faecal biomarkers for diagnosis and prediction of disease course in treatment‐naïve patients with IBD 41
Performance of the Use of Genetic Information to Assess the Risk of Colorectal Cancer in the Basque Population 41
Characterization of Inflammatory Bowel Disease Heterogeneity Using Serum Proteomics: A Multicenter Study 41
Human CAZyme genes polymorphism and risk of IBS: a population-based study 41
TRPM8polymorphisms associated with increased risk of IBS-C and IBS-M 41
Crohn's Disease Is Associated With Activation of Circulating Innate Lymphoid Cells 40
Intestinal Barrier and Permeability in Health, Obesity and NAFLD 40
Downregulated Mucosal Autophagy, Alpha Kinase-1 and IL-17 Signaling Pathways in Active and Quiescent Ulcerative Colitis 39
Rare Hypomorphic Sucrase Isomaltase Variants in Relation to Irritable Bowel Syndrome Risk in UK Biobank 39
miR-16 and miR-103 impact 5-HT4 receptor signalling and correlate with symptom profile in irritable bowel syndrome 38
Combining Asian and European genome-wide association studies of colorectal cancer improves risk prediction across racial and ethnic populations 38
Prototypical pacemaker neurons interact with the resident microbiota 38
Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes 37
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study 37
HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis 36
Dynamics of the human gut microbiome in inflammatory bowel disease 36
Detailed Transcriptional Landscape of Peripheral Blood Points to Increased Neutrophil Activation in Treatment-Naïve Inflammatory Bowel Disease 36
Metabolic Profiling of Plasma in Patients with Irritable Bowel Syndrome after a 4-Week Starch- and Sucrose-Reduced Diet 36
Identification and validation of a blood- based diagnostic lipidomic signature of pediatric inflammatory bowel disease 36
The alternative serotonin transporter promoter P2 impacts gene function in females with irritable bowel syndrome 36
Sucrase-isomaltase 15Phe IBS risk variant in relation to dietary carbohydrates and faecal microbiota composition 36
Genetic Variants as Predictors of the Success of Colorectal Cancer Treatments 35
Neuropeptide S Receptor 1 Gene Polymorphism Is Associated With Susceptibility to Inflammatory Bowel Disease 35
The serotonin receptor 3E variant is a risk factor for female IBS-D 35
Characterisation of the Circulating Transcriptomic Landscape in Inflammatory Bowel Disease Provides Evidence for Dysregulation of Multiple Transcription Factors Including NFE2, SPI1, CEBPB, and IRF2 34
High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis 33
Circulating white blood cell traits and colorectal cancer risk: A Mendelian randomisation study 33
Severe pathogenic variants of intestinal sucrase-isomaltase interact avidly with the wild type enzyme and negatively impact its function and trafficking 33
Clusters of community-dwelling individuals empirically derived from stool diaries correspond with clinically meaningful outcomes 33
Functional Variation in Human CAZyme Genes in Relation to the Efficacy of a Carbohydrate-Restricted Diet in IBS Patients 32
Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease 32
Sucrase-isomaltase genotype and response to a starch-reduced and sucrose-reduced diet in IBS-D patients 32
Local genetic variation of inflammatory bowel disease in Basque population and its effect in risk prediction 31
Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota 30
Sucrase-isomaltase genotype and response to a starch-reduced and sucrose-reduced diet in IBS-D patients 30
Sucrase Isomaltase Dysfunction Reduces Sucrose Intake in Mice and Humans 30
Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes 30
Hypomorphic SI genetic variants are associated with childhood chronic loose stools 30
Identification of a Genetic Variation in ERAP1 Aminopeptidase that Prevents Human Cytomegalovirus miR-UL112-5p-Mediated Immunoevasion 30
Erratum: A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis 29
Totale 5.766
Categoria #
all - tutte 55.591
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.591


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202281 0 0 0 0 0 0 0 0 46 0 33 2
2022/2023474 73 0 5 69 20 67 1 26 58 18 122 15
2023/2024532 40 55 61 50 40 45 16 86 44 18 26 51
2024/20251.365 16 94 39 66 83 112 60 50 229 72 273 271
2025/20263.999 189 642 711 521 172 100 826 222 234 382 0 0
Totale 6.451